É. Vivier
Immunology · 2000–2019
A researcher in the Science corpus: 17 papers; trusts 5 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Immunology — 335 citations into it
Whom É. Vivier trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
- D. Raulet
- Peter Parham
- L. Lanier
- D. Artis
- J. Nussbaum
- H. Spits
- G. Trinchieri
- Ari B. Molofsky
- M. Smyth
- J. O’Leary
Who trusts É. Vivier overall
Papers from É. Vivier's perspective
Ordered by how strongly the researchers É. Vivier trusts endorse each paper. Same corpus, a different order for every researcher.
- Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity (Nature)
- Systemically dispersed innate IL-13–expressing cells in type 2 immunity (Proceedings of the National Academy of Sciences of the United States of America)
- Effectiveness of Donor Natural Killer Cell Alloreactivity in Mismatched Hematopoietic Transplants (Science)
- Licensing of natural killer cells by host major histocompatibility complex class I molecules (Nature)
- Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus (Nature Immunology)
- A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules. (Blood)
- Roles of the NKG2D immunoreceptor and its ligands (Nature reviews. Immunology)
- ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor. (Immunity)
- Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion. (Blood)
- The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor (Nature)
Their papers
- The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide (2013) — 1,872 citations
- TLR3 Deficiency in Patients with Herpes Simplex Encephalitis (2007) — 1,116 citations
- Harnessing innate immunity in cancer therapy (2019) — 809 citations
- Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells (2018) — 1,036 citations
- Natural killer cells and other innate lymphoid cells in cancer (2018) — 844 citations
- Innate Lymphoid Cells: 10 Years On. (2018) — 1,825 citations
- Innate lymphoid cells — a proposal for uniform nomenclature (2013) — 2,331 citations
- Targeting natural killer cells and natural killer T cells in cancer (2012) — 829 citations
- Innate or Adaptive Immunity? The Example of Natural Killer Cells (2011) — 2,683 citations
- The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans (2009) — 688 citations
- Maturation of mouse NK cells is a 4-stage developmental program. (2009) — 788 citations
- Functions of natural killer cells (2008) — 3,827 citations
- Human NK cell education by inhibitory receptors for MHC class I. (2006) — 1,253 citations
- CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor–β–dependent manner (2005) — 877 citations
- Natural-killer cells and dendritic cells: "l'union fait la force". (2005) — 679 citations
- Natural Killer Cell Signaling Pathways (2004) — 745 citations
- Association of signal‐regulatory proteins β with KARAP/DAP‐12 (2000) — 111 citations